Suspected paclitaxel-induced pneumonitis

14Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report two patients with advanced gastric cancer with suspected paclitaxel-induced interstitial pneumonitis. Case 1, a 66-year-old man with recurrent gastric cancer, was treated weekly with paclitaxel. After 11 administrations of paclitaxel, he developed a nonproductive cough and dyspnea. Computed tomography (CT) scan showed extensive bilateral areas of ground-glass attenuation. He did not respond to corticosteroid, and died 57 days after the last paclitaxel administration. Case 2, a 61-year-old man with gastric cancer and liver metastasis, was treated with weekly paclitaxel. The liver metastasis was dramatically reduced in size, but he developed a nonproductive cough and dyspnea after 21 administrations of paclitaxel. He did not respond to high-dose corticosteroid, and died 50 days after the last paclitaxel administration. Although it is a rare complication, paclitaxel-induced interstitial pneumonitis needs to be considered in the differential diagnosis when patients treated with paclitaxel present with fever, nonproductive cough, and dyspnea. © 2006 International and Japanese Gastric Cancer Association.

Cite

CITATION STYLE

APA

Shitara, K., Ishii, E., Kondo, M., & Sakata, Y. (2006). Suspected paclitaxel-induced pneumonitis. Gastric Cancer, 9(4), 325–328. https://doi.org/10.1007/s10120-006-0388-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free